Areva, BioAlliance, Legrand, Robertet: French Equity Preview

The following is a list of companies that may have unusual share-price changes in Paris. Stock symbols are in parentheses after company names. Share prices are from the last close.

France’s CAC 40 Index (CAC) rose 26.44, or 0.7 percent, to 4,060.76 in Paris. The SBF-120 Index gained 0.6 percent.

Areva SA (CEI) : The biggest supplier of nuclear fuel and services scrapped its dividend payout for 2010 and reported full-year profit that missed estimates on charges. Net income rose 60 percent to 883 million euros, less than the 1.06 billion-euro estimate in a Bloomberg survey of analysts. The shares fell 3.7 percent to 33.55 euros.

BioAlliance Pharma SA (BIO) : The pharmaceutical company said net income last year was 2.81 million euros, compared with a loss of 15.4 million euros a year earlier. The shares rose 2 percent to 6 euros.

Legrand SA (LR) : Kohlberg Kravis Roberts & Co. and Wendel (MF) said they plan to sell 40 million shares in the world’s largest maker of wiring devices such as plugs and switches, equivalent to a 15 percent stake in the company. Legrand shares fell 0.1 percent to 30.29 euros.

Robertet SA (RBT) : The maker of liquid flavorings, perfumes and aromatic ingredients said profit last year rose to about 23 million euros from 14.4 million euros in 2009. The stock fell 0.5 percent to 115.50 euros.

To contact the reporters on this story: Alan Katz in Paris at Marthe Fourcade in Paris at

To contact the editor responsible for this story: Vidya Root at

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.